Concepedia

Helen Thackray

HT

20

Publications

867

Citations

14

H-Index

1992

Active since

Affiliations

GlycoMimetics (United States)(Current)

University of California, Davis

The University of Queensland

Cleveland Clinic

University of Michigan

Helen Thackray is an author at GlycoMimetics (United States) specializing in medicine, immunology, and pharmacotherapy.

Top concepts

Publications per year

1992–2022

20

Publications

20

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use

Marilyn J. Telen, Ted Wun, Timothy L. McCavit et al. · Blood · 2015 · 204 citations · Full text

A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis

Helen Thackray, Robin H. Steinhorn, William F. Walsh et al. · PEDIATRICS · 2011 · 95 citations

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

Daniel J. DeAngelo, Brian A. Jonas, Jane L. Liesveld et al. · Blood · 2021 · 92 citations · Full text

, , +16

Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates

Leonard E. Weisman, Helen Thackray, Joseph A. Garcia‐Prats et al. · Antimicrobial Agents and Chemotherapy · 2009 · 86 citations · Full text

Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

Ted Wun, Lori Styles, Laura DeCastro et al. · PLoS ONE · 2014 · 68 citations · Full text

Rows per page

1–5 of 20